This article provides a detailed guide for researchers and drug development professionals on leveraging high-fidelity Cas variants to overcome the critical challenge of off-target effects in CRISPR genome editing.
The immunogenicity of the Cas9 nuclease presents a significant challenge for the clinical application of in vivo CRISPR-Cas9 therapies.
This article provides a comprehensive analysis of genetic mosaicism, a prevalent challenge that reduces the efficiency and reliability of CRISPR-based gene editing in both model organisms and therapeutic applications.
This article provides a comprehensive overview of the critical link between delivery methods and the accuracy of CRISPR-Cas9 gene editing in target cells, tailored for researchers and drug development professionals.
As CRISPR-based gene editing rapidly advances toward clinical applications, the precise detection of off-target effects has become a critical pillar for ensuring therapeutic safety and efficacy.
Prime editing represents a transformative advance in precision genome editing, yet its efficacy is critically dependent on the design of the prime editing guide RNA (pegRNA).
This guide provides researchers, scientists, and drug development professionals with a comprehensive framework for diagnosing and resolving low CRISPR-Cas9 editing efficiency.
Homology-Directed Repair (HDR) is the cornerstone of precise CRISPR-Cas9 genome editing, enabling targeted gene insertions, corrections, and the creation of sophisticated disease models.
This article provides researchers, scientists, and drug development professionals with a comprehensive, up-to-date guide on addressing CRISPR off-target effects.
This comprehensive review examines current CRISPR-Cas9 gene therapy protocols for sickle cell anemia, targeting researchers and drug development professionals.